Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

15th International Workshop on Chronic Lymphocytic Leukaemia (iwCLL 2013) /
European Research Initiative in CLL (ERIC) and iwCLL explained

9th - 11th Sep 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.10.13
Views: 4852

Dr Emil Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain

Dr Montserrat from Barcelona, Spain, talks to ecancer from the iwCLL 2013.  He outlines what the European Research Initiative in CLL (ERIC) is and why it is important.  He emphasises why iwCLL has become such an important meeting in the CLL calendar, including the inclusion of young researchers and the worldwide expertise that now gets together at this meeting to challenge current paradigms.  Dr Montserrat clarifies what the next iwCLL meeting will provide attendees, and give clinicians treating CLL advice on how patients should best be managed with the current knowledge we now have about this cancer.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation